Acetyl-L-carnitine treatment in minimal hepatic encephalopathy.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/18357530
Conclusion of this study
The benefits of ALC in comparison with placebo are demonstrated in greater reductions in serum ammonia levels, as well as in improvements of neuropsychological functioning.
Supplements analyzed in this study
|
Health conditions analyzed in this study
|
||
|
Functions related to this study
|
||
|
||
|
||
|
Body systems related to this study
 Muscular System |
 Nervous System |
